课题基金 / 基金详情

Mechanisms of RNA-DNA repair

Mechanisms of RNA-DNA repair
RNA-DNA 修复机制
批准号:
10336801
负责人:
Richard T Pomerantz
金额:
$36.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-08 至 2024-03-31
关键词:

项目摘要

项目成果

Richard T Pomerantz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Polymerase theta (Polq) is a unique polymerase-helicase fusion protein that performs multiple functions in DNA repair in mammalian cells. Polq was initially characterized as a translesion DNA polymerase due to its ability to perform replication opposite DNA lesions in vitro, and Polq translesion synthesis (TLS) has now been confirmed in cells. Our laboratory and others have also identified an essential role for Polq in repairing double-strand breaks (DSBs) via microhomology-mediated end-joining (MMEJ). Polq has also been implicated in replication repair, base excision repair, somatic hypermutation and class-switch recombination. Whether this unique and error- prone polymerase exhibits additional activities in DNA repair remains unknown. Here, we discover that recombinant human Polq exhibits robust reverse transcriptase (RT) activity, whereas all other human DNA polymerases tested from the A, B, Y and X families fail to perform reverse transcription beyond 1-2 nucleotides. Polq generates identical reverse transcription products as retroviral RTs. Unexpectedly, Polq exhibits a significantly higher velocity and fidelity of deoxyribonucleotide incorporation on RNA versus DNA templates. These preliminary studies identify Polq as a novel RT in mammalian cells. We plan to elucidate the molecular basis of Polq RT activity in vitro and investigate multiple RNA-templated DNA repair (RNA-DNA repair) mechanisms in cells and in vivo by developing the following Aims: 1. To characterize Polq reverse transcriptase activity in vitro; 2. To elucidate the molecular basis of Polq reverse transcriptase activity; 3. To investigate RNA-DNA repair using cellular and animal models. We anticipate that these studies will confirm and characterize Polq RT activity in vitro and in a biological setting, and elucidate novel mechanisms of mammalian RNA-DNA repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure Based Design of Pol-theta inhibitors
  • 批准号:
    10323627
  • 项目类别:
  • 资助金额:
    $38.59万
  • 财政年份:
    2021
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
Next-generation precision medicine for targeting recombination-deficient cancers
  • 批准号:
    9909705
  • 项目类别:
  • 资助金额:
    $29.9万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
PolQ as a novel therapeutic target in AML
  • 批准号:
    10545175
  • 项目类别:
  • 资助金额:
    $52.39万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
Mechanisms of RNA-DNA repair
  • 批准号:
    10385826
  • 项目类别:
  • 资助金额:
    $37.73万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
国内基金
海外基金
环状RNA介导DNA损伤-炎症通路调控NNK 诱导的肺癌发生
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    华秋翰
  • 依托单位:
可编程的智能响应型“DNA纳米机器人”核酸自组装递释系统用于小激活RNA疗法和化疗协同抗肿瘤
  • 批准号:
    2024Y9099
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    陈昌买
  • 依托单位:
长非编码RNA P21-DIPOT在DNA损伤修复中的作用机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王玉茗
  • 依托单位:
诱导型ADAR1通过DNA-RNA杂合体堆积持续启动滞育样重编程介导舌鳞癌细胞休眠的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    李静远
  • 依托单位: